Some GLP-1 companies facing lawsuits over vision loss. What to know - WCVB

As reported by WCVB Boston

Some of the companies that produce GLP-1 drugs like Ozempic and Zepbound are facing lawsuits alleging that the drugs caused vision loss. Here's what to know.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on WCVB Boston ↗

Market Samachar is a news aggregator. This article was originally published by WCVB Boston. Tap the button above to read the full story on their site.

INDIAN Swastika Infra IPO Day 3: Issue subscribed over 1.6x; GMP signals 5% premium — Check key details Markets-Economic Times
COMPANIES PB Fintech shares rebound 4% after massive 36% crash. What are Jefferies, others saying? Stocks-Markets-Economic Times
COMPANIES Chalet Hotels among 3 stocks closed above VWAP Stocks-Markets-Economic Times
INDIAN German Green Steel IPO opens today: GMP indicates 20% potential listing gain. Should you subscribe? Markets-Economic Times
INDIAN Elevate Campuses IPO Day 3: GMP, subscription status and key details. Should you subscribe? Markets-Economic Times
COMPANIES JK Cement among 4 stocks showing RSI trending up Stocks-Markets-Economic Times
INDIAN AceVector IPO opens today: Check GMP and other key details Markets-Economic Times
INDIAN NSE shares fall 2%, trade marginally above IPO price after debut. Why are Macquarie, other brokerages bullish? Markets-Economic Times

Some GLP-1 companies facing lawsuits over vision loss. What to know - WCVB

More from Market Samachar